Latest / Texas News Today | 2 Min News | The Daily News Now!
FDA Eyes Alzheimer's Drug Lecanemab | Texas News
FDA eyes groundbreaking Alzheimer’s drug Lecanemab, which may slow cognitive decline by 27% in early-stage patients—potentially offering families more time with loved ones, though side effects like brain swelling exist; approval could come by early January, marking a historic step in Alzheimer’s treatment. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:advertise@thednn.ai This is an automated, high-level news summary based on public reporting.Report issues to feedback@thednn.ai. View sources & latest…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.